CVR: 37064408
Secondary names: Eurofins Pharma Holding Denmark A/S, Eurofins BioPharma Product Testing & Professional Scientific Services Denmark Holding A/S
Eurofins BioPharma Product Testing Denmark Holding A/S is a Danish company of the type Aktieselskab based in Galten, founded in 2015. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Stefánia Pcolová. The company is owned by Eurofins Pharma Services LUX Holding SARL. In 2025, the company reported a gross profit of DKK -163,266 and a net result of DKK 8,356,614 compared with DKK -1,877,244 the year before. Equity amounted to DKK 24,787,263.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at udøve investeringsvirksomhed, herunder ved besiddelse af kapitalandele i et eller flere datterselskaber.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | -163 t. | 8.4 mio. | 71 mio. | 24.8 mio. | 0 | |
| 2024 | -104 t. | -1.9 mio. | 62.8 mio. | 16.4 mio. | - | |
| 2023 | -93 t. | 3.6 mio. | 66.5 mio. | 20.1 mio. | - | |
| 2022 | -88 t. | 7.9 mio. | 65.1 mio. | 18.8 mio. | - | |
| 2021 | -82 t. | 4.3 mio. | 61.2 mio. | 15.2 mio. | - | |
| 2020 | -80 t. | 5.3 mio. | 61.9 mio. | 15.9 mio. | - | |
| 2019 | -81 t. | 3.3 mio. | 59.6 mio. | 13.6 mio. | - | |
| 2018 | -83 t. | 8.1 mio. | 60.3 mio. | 15 mio. | - | |
| 2017 | -110 t. | 910 t. | 59.9 mio. | 14.4 mio. | - | |
| 2016 | -175 t. | 584 t. | 62.6 mio. | 14 mio. | - |
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorCompared to 50.000 companies in Ikke-finansielle holdingselskaber
Comparison is based on industry median values
Eurofins BioPharma Product Testing Denmark Holding A/S has published its annual report for 2025. Gross profit came to DKK -163,266, and the net result was DKK 8,356,614.
Eurofins BioPharma Product Testing Denmark Holding A/S has published its annual report for 2024. Gross profit came to DKK -103,878, and the net result was DKK -1,877,244.
Eurofins BioPharma Product Testing Denmark Holding A/S has published its annual report for 2023. Gross profit came to DKK -92,640, and the net result was DKK 3,606,153.
Eurofins BioPharma Product Testing Denmark Holding A/S has published its annual report for 2022. Gross profit came to DKK -87,649, and the net result was DKK 7,900,329.
Eurofins BioPharma Product Testing Denmark Holding A/S has published its annual report for 2021. Gross profit came to DKK -82,400, and the net result was DKK 4,303,830.
Eurofins BioPharma Product Testing Denmark Holding A/S has published its annual report for 2020. Gross profit came to DKK -79,990, and the net result was DKK 5,272,479.
Eurofins BioPharma Product Testing Denmark Holding A/S has published its annual report for 2019. Gross profit came to DKK -80,588, and the net result was DKK 3,326,352.
Eurofins BioPharma Product Testing Denmark Holding A/S has published its annual report for 2018. Gross profit came to DKK -83,448, and the net result was DKK 8,065,821.
As of May 10, 2019, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Eurofins BioPharma Product Testing Denmark Holding A/S.
As of May 10, 2019, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Eurofins BioPharma Product Testing Denmark Holding A/S.
As of April 9, 2019, Marco Antonio Giuseppe Baeli has joined the board of directors of Eurofins BioPharma Product Testing Denmark Holding A/S.
As of April 9, 2019, Berthold Jakob Georg Hackl has left the board of directors of Eurofins BioPharma Product Testing Denmark Holding A/S.
As of October 15, 2018, Jan Rando has joined the board of directors of Eurofins BioPharma Product Testing Denmark Holding A/S.
As of October 15, 2018, Jacob Klinge Jacobsen has left the board of directors of Eurofins BioPharma Product Testing Denmark Holding A/S.
Eurofins BioPharma Product Testing Denmark Holding A/S has published its annual report for 2017. Gross profit came to DKK -109,688, and the net result was DKK 910,248.
As of February 9, 2018, Jacob Klinge Jacobsen has joined the board of directors of Eurofins BioPharma Product Testing Denmark Holding A/S.
As of February 9, 2018, Thomas Gjelsnes has left the board of directors of Eurofins BioPharma Product Testing Denmark Holding A/S.
As of January 1, 2018, Stefánia Pcolová is registered as adm. dir. of Eurofins BioPharma Product Testing Denmark Holding A/S.
As of January 1, 2018, Thomas Gjelsnes has stepped down as adm. dir. of Eurofins BioPharma Product Testing Denmark Holding A/S.
Eurofins BioPharma Product Testing Denmark Holding A/S has published its annual report for 2016. Gross profit came to DKK -174,784, and the net result was DKK 583,998.
Eurofins BioPharma Product Testing Denmark Holding A/S has published its interim report for the period August 31, 2015 – December 31, 2015.
As of August 31, 2015, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Eurofins BioPharma Product Testing Denmark Holding A/S.
As of August 31, 2015, Svend Aage Linde has joined the board of directors of Eurofins BioPharma Product Testing Denmark Holding A/S.
As of August 31, 2015, Thomas Gjelsnes has joined the board of directors of Eurofins BioPharma Product Testing Denmark Holding A/S.
As of August 31, 2015, Berthold Jakob Georg Hackl has joined the board of directors of Eurofins BioPharma Product Testing Denmark Holding A/S.
As of August 31, 2015, Thomas Gjelsnes is registered as adm. dir. of Eurofins BioPharma Product Testing Denmark Holding A/S.
As of August 31, 2015, is registered as an owner of Eurofins BioPharma Product Testing Denmark Holding A/S with an ownership share of 100%.
Eurofins BioPharma Product Testing Denmark Holding A/S was founded on August 31, 2015.
Companies in the same industry and area
CVR 37757322
CVR 35478744
CVR 41373873
CVR 39576147
CVR 28114931
companydata.dk